1 study found for:    NCT01020838
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology
Condition: Alzheimer Disease
Intervention: Drug: Florbetaben (BAY94-9172)

Indicates status has not been verified in more than two years